MindMed exchanges 8M common shares for pre-funded warrants at $0.001 exercise price

Definium Therapeutics, Inc.

Exchanged 8,000,000 common shares held by Commodore Capital and Deep Track Biotechnology for pre-funded warrants to purchase 8,000,000 common shares at $0.001 each.
Warrants are exercisable immediately, no expiration, subject to 9.99% beneficial ownership limitation (can be increased to 19.99% with 61 days notice).
Company and holders amended Registration Rights Agreement to register resale of warrant shares; prospectus supplement filed with SEC.
Exchange structured as exempt transaction under Section 3(a)(9) of the Securities Act; no commissions paid.
Holders originally acquired the shares in a March 2024 private placement of 12.5M shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.